NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Antihistamines, Amantadine and Evolution of COVID-19
Antihistamines, Amantadine and Evolution of COVID-19
RecruitingN/A
Sponsor: Consorci Sanitari de Terrassa
Conditions: COVID-19
Interventions: Antihistamine, Amantadine
Countries: Spain
The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.
Eligibility overview
Sex: ALL
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: Patients having chronic treatment with antihistamines or amantadine - Exclusion Criteria: None \-
Locations (2)
- Terrassa, Barcelona, Spain
- Terrassa, Barcelona, Spain